SMLR News and Press, Semler Scientific Inc From 03/20/23

2023-03-20 17:35:07 ET Major earnings expected after the bell on Tuesday include: NIKE ( NKE ) GameStop ( GME ) Array Technologies ( ARRY ) AAR Corp. ( AIR ) HealthEquity ( HQY ) For further details see: Notable earnings after Tuesday's close

Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting PR Newswire SANTA CLARA, Calif. , March 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that pr...

Summary The recent drastic drop in stock price is grossly exaggerated. Value proposition of QuantaFlo, Semler's main product, remains intact. We believe that stock prices will revalue as the initial HCC code scare dissipates. Semler Scientific ( SMLR ) is a micro-cap b...

Summary Kingdom Capital Advisors (KCA Value Composite) returned 7.19% net of fees in the fourth quarter. KCA finished the year with over 40% net outperformance versus the S&P 500. We are pleased by our performance in 2022 and look forward to improving on our process in 2023. ...

Summary The CMS advanced notice for Medicare advantage for the year 2024 removed the PAD HCC code QuantaFlo uses. This could negatively impact QuantaFlo's usage. Semler's stock crashed as a result. I'm not selling my shares because I still believe QuantaFlo is great for patient outc...

Semler Scientific ( NASDAQ: SMLR ) is down ~37% in Monday afternoon trading amid much higher than usual volume. Average daily volume is ~27.5K shares. As of 200p ET, ~480K shares had traded hands, more than 17 times higher than usual. The volatility could be because of a poten...

Summary Semler Scientific downwardly revised revenue for the full-year 2022. Operating expenses are expected to drop in the fourth quarter but will still be up year-over-year. Fixed fee and variable revenue mix will probably remain a headwind for the company in the near term. ...

Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible PR Newswire SANTA CLARA, Calif. , Dec. 14, 2022 /PRNewswire/ -- Semler Sci...

Semler Announces Investment in Monarch Medical Technologies PR Newswire SANTA CLARA, Calif. , Dec. 12, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficie...

B Riley has downgraded Semler Scientific ( NASDAQ: SMLR ) to neutral from buy due to increased near-term risks associated with Semler's ( SMLR ) variable-fee revenue as a result of CVS' ( CVS ) acquisition of Signify Health, the company's second-largest customer. A...